What did people with knee pain report?
In 2021, Edwin Lee and Blake Padgett published a review of 17 patients’ records from one Florida clinic. They reached 16 people by phone and asked them to recall their knee pain before and after an injection. Most had received the injection six months to a year before the survey.
Eleven of the 12 people who received BPC-157 alone reported less pain. Three of the four who also received a second peptide, thymosin beta-4, reported relief. Everyone received BPC-157, so the survey leaves open how many people would have felt better anyway. The authors also lacked follow-up scans to see whether a tear had healed.
How much force could a repaired rat tendon bear?
In a 2026 experiment, researchers surgically cut and repaired an Achilles tendon in each of 32 male rats. They assigned the rats at random to four groups of eight. One group received BPC-157, one received TB-500, one received both peptides, and a control group received neither.
At four weeks, researchers examined four tendons from each group under a microscope and pulled the other four until they broke. One stain showed a stronger signal for type I collagen in the BPC-157 group than in controls. The BPC-157 tendons also bore more force in the pulling test, but the difference from controls fell short of statistical significance. Seeing a difference under a microscope leaves the question of tendon strength open, even in these rats.
What did the human safety pilot check?
Lee and Kailynd Burgess followed two adults who had previously received BPC-157 by infusion. Across three days, the researchers checked vital signs and blood tests and asked about side effects. Neither participant reported side effects during those visits. Two people observed for three days tell us little about how often a rare problem occurs or what might happen months later.
Of these three studies, only the knee survey asked patients whether their pain improved. The rat study included a control group but tested a different injury in a different species. Whether BPC-157 helps a person return to walking, work, or sport after a tendon injury remains an open question.
Frequently asked questions
Why did the rat study use random assignment?
Assignment by chance helps prevent researchers from placing the healthiest animals in a particular group. The people examining the tendon samples also worked without knowing which group each sample came from.
What would help answer the question about walking after an injury?
A human study could enroll people with the same diagnosed tendon injury, randomly assign them to BPC-157 or a comparison group, and give both groups the same rehabilitation. Measuring walking ability before treatment and at the same follow-up visits would allow a direct comparison.